{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T21:23:01Z","timestamp":1772486581435,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T00:00:00Z","timestamp":1445817600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12889-015-2424-8","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T17:12:09Z","timestamp":1445879529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study"],"prefix":"10.1186","volume":"15","author":[{"given":"V.","family":"Ramesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam","family":"Salotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,26]]},"reference":[{"key":"2424_CR1","first-page":"22","volume":"949","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Control of the leishmaniases. World Health Organ Tech Rep Ser. 2010;949:22\u20136.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2424_CR2","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671.","journal-title":"PLoS One"},{"key":"2424_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/j.1365-2133.2000.03603.x","volume":"143","author":"EE Zijlstra","year":"2000","unstructured":"Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Br J Dermatol. 2000;143:136\u201343.","journal-title":"Br J Dermatol"},{"key":"2424_CR4","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1365-3156.2007.01854.x","volume":"12","author":"V Ramesh","year":"2007","unstructured":"Ramesh V, Singh R, Salotra P. Short communication: post-kala-azar dermal leishmaniasis--an appraisal. Trop Med Int Heal. 2007;12:848\u201351.","journal-title":"Trop Med Int Heal"},{"key":"2424_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1346-8138.1998.tb02361.x","volume":"25","author":"H Ono","year":"1998","unstructured":"Ono H, Ghoreishi M, Yokozeki H, Katayama I, Nishioka K. A case of Post-kala-azar dermal leishmaniasis. J Dermatol. 1998;25:118\u201320.","journal-title":"J Dermatol"},{"key":"2424_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1179\/2047773213Y.0000000097","volume":"107","author":"A Badirzadeh","year":"2013","unstructured":"Badirzadeh A, Mohebali M, Ghasemian M, Amini H, Zarei Z, Akhoundi B, et al. Cutaneous and post kala-azar dermal leishmaniasis caused by Leishmania infantum in endemic areas of visceral leishmaniasis, northwestern Iran 2002\u20132011: a case series. Pathog Glob Health. 2013;107:194\u20137.","journal-title":"Pathog Glob Health"},{"key":"2424_CR7","doi-asserted-by":"publisher","first-page":"e832","DOI":"10.1371\/journal.pntd.0000832","volume":"4","author":"D Mondal","year":"2010","unstructured":"Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain MS, Kroeger A, et al. Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh. PLoS Negl Trop Dis. 2010;4:e832.","journal-title":"PLoS Negl Trop Dis"},{"key":"2424_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"SL Croft","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006;19:111\u201326.","journal-title":"Clin Microbiol Rev"},{"key":"2424_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1086\/505079","volume":"194","author":"R Singh","year":"2006","unstructured":"Singh R, Kumar D, Ramesh V, Negi NS, Singh S, Salotra P. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. J Infect Dis. 2006;194:302\u20136.","journal-title":"J Infect Dis"},{"key":"2424_CR10","first-page":"582","volume":"127","author":"CP Thakur","year":"2008","unstructured":"Thakur CP, Thakur S, Narayan S, Sinha A. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate. Indian J Med Res. 2008;127:582\u20138.","journal-title":"Indian J Med Res"},{"key":"2424_CR11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1179\/000349809X12554106963438","volume":"103","author":"D Kumar","year":"2009","unstructured":"Kumar D, Ramesh V, Verma S, Ramam M, Salotra P. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine. Ann Trop Med Parasitol. 2009;103:727\u201330.","journal-title":"Ann Trop Med Parasitol"},{"key":"2424_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.4269\/ajtmh.2012.11-0467","volume":"86","author":"VNR Das","year":"2012","unstructured":"Das VNR, Ranjan A, Pandey K, Singh D, Verma N, Das S, et al. Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar. India Am J Trop Med Hyg. 2012;86:959\u201361.","journal-title":"India Am J Trop Med Hyg"},{"key":"2424_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1046\/j.1365-4362.2002.01676.x","volume":"41","author":"R Mittal","year":"2002","unstructured":"Mittal R, Behl PN, Srivastava G. Post-kala-azar dermal leishmanasis occurring after 10\u00a0years of treated kala azar. Int J Dermatol. 2002;41:875\u20136.","journal-title":"Int J Dermatol"},{"key":"2424_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1128\/JCM.39.3.849-854.2001","volume":"39","author":"P Salotra","year":"2001","unstructured":"Salotra P, Sreenivas G, Pogue GP, Lee N, Nakhasi HL, Ramesh V, et al. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis. J Clin Microbiol. 2001;39:849\u201354.","journal-title":"J Clin Microbiol"},{"key":"2424_CR15","doi-asserted-by":"publisher","first-page":"e10107","DOI":"10.1371\/journal.pone.0010107","volume":"5","author":"S Verma","year":"2010","unstructured":"Verma S, Kumar R, Katara GK, Singh LC, Negi NS, Ramesh V, et al. Quantification of parasite load in clinical samples of leishmaniasis patients: Il-10 level correlates with parasite load in visceral leishmaniasis. PLoS One. 2010;5:e10107.","journal-title":"PLoS One"},{"key":"2424_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/0378-6323.60553","volume":"76","author":"V Ramesh","year":"2010","unstructured":"Ramesh V, Kumar J, Kumar D, Salotra P. A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis. Indian J Dermatol Venereol Leprol. 2010;76:138\u201344.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2424_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2133.2011.10402.x","volume":"165","author":"V Ramesh","year":"2011","unstructured":"Ramesh V, Katara GK, Verma S, Salotra P. Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis. Br J Dermatol. 2011;165:411\u20134.","journal-title":"Br J Dermatol"},{"key":"2424_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2340\/00015555-1582","volume":"94","author":"V Ramesh","year":"2014","unstructured":"Ramesh V, Avishek K, Sharma V, Salotra P. Combination therapy with amphotericin-B and miltefosine for post-kala-azar dermal leishmaniasis: a preliminary report. Acta Derm Venereol. 2014;94:242\u20133.","journal-title":"Acta Derm Venereol"},{"key":"2424_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","volume":"6","author":"S Sundar","year":"2001","unstructured":"Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Heal. 2001;6:849\u201354.","journal-title":"Trop Med Int Heal"},{"key":"2424_CR20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/tmi.12047","volume":"18","author":"S Verma","year":"2013","unstructured":"Verma S, Bhandari V, Avishek K, Ramesh V, Salotra P. Reliable diagnosis of post-kala-azar dermal leishmaniasis (PKDL) using slit aspirate specimen to avoid invasive sampling procedures. Trop Med Int Heal. 2013;18:268\u201375.","journal-title":"Trop Med Int Heal"},{"key":"2424_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1365-3156.2009.02279.x","volume":"14","author":"M Boelaert","year":"2009","unstructured":"Boelaert M, Meheus F, Sanchez A, Singh SP, Vanlerberghe V, Picado A, et al. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar. India Trop Med Int Heal. 2009;14:639\u201344.","journal-title":"India Trop Med Int Heal"},{"key":"2424_CR22","first-page":"294","volume":"31","author":"MA Salam","year":"2013","unstructured":"Salam MA, Siddiqui MA, Nabi SG, Bhaskar KRH, Mondal D. Post-kala-azar dermal leishmaniasis with mucosal involvement: an unusual case presentation including successful treatment with miltefosine. J Heal Popul Nutr. 2013;31:294\u20137.","journal-title":"J Heal Popul Nutr"},{"key":"2424_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","volume":"3","author":"EE Zijlstra","year":"2003","unstructured":"Zijlstra EE, Musa AM, Khalil EAG, El-Hassan IM, El-Hassan AM. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003;3:87\u201398.","journal-title":"Lancet Infect Dis"},{"key":"2424_CR24","first-page":"295","volume":"123","author":"P Salotra","year":"2006","unstructured":"Salotra P, Singh R. Challenges in the diagnosis of post kala-azar dermal leishmaniasis. Indian J Med Res. 2006;123:295\u2013310.","journal-title":"Indian J Med Res"},{"key":"2424_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.7883\/yoken.65.315","volume":"65","author":"SA Nasreen","year":"2012","unstructured":"Nasreen SA, Hossain MA, Paul SK, Mahmud MC, Ahmed S, Ghosh S, et al. PCR-based detection of Leishmania DNA in skin samples of post kala-azar dermal leishmaniasis patients from an endemic area of Bangladesh. Jpn J Infect Dis. 2012;65:315\u20137.","journal-title":"Jpn J Infect Dis"},{"key":"2424_CR26","first-page":"229","volume":"62","author":"PP Reddi","year":"1994","unstructured":"Reddi PP, Amin AG, Khandekar PS, Talwar GP. Molecular definition of unique species status of Mycobacterium w; a candidate leprosy vaccine strain. Int J Lepr Other Mycobact Dis. 1994;62:229\u201336.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"2424_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1017\/S0031182012001850","volume":"140","author":"R Tandon","year":"2013","unstructured":"Tandon R, Misra P, Soni VK, Bano N, Misra-Bhattacharya S, Dube A. Unresponsiveness of Mycobacterium w vaccine in managing acute and chronic Leishmania donovani infections in mouse and hamster. Parasitology. 2013;140:435\u201344.","journal-title":"Parasitology"},{"key":"2424_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1756-3305-6-196","volume":"6","author":"P Desjeux","year":"2013","unstructured":"Desjeux P, Ghosh RS, Dhalaria P, Strub-Wourgaft N, Zijlstra EE. Report of the Post Kala-azar Dermal Leishmaniasis (PKDL) Consortium Meeting, New Delhi, India, 27\u201329 June 2012. Parasit Vectors. 2013;6:196.","journal-title":"Parasit Vectors"},{"key":"2424_CR29","doi-asserted-by":"publisher","first-page":"e2603","DOI":"10.1371\/journal.pntd.0002603","volume":"8","author":"S Burza","year":"2014","unstructured":"Burza S, Sinha PK, Mahajan R, Lima MA, Mitra G, Verma N, et al. Five-year field results and long-term effectiveness of 20\u00a0mg\/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar. India PLoS Negl Trop Dis. 2014;8:e2603.","journal-title":"India PLoS Negl Trop Dis"},{"key":"2424_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4269\/ajtmh.14-0259","volume":"92","author":"S Sundar","year":"2015","unstructured":"Sundar S, Singh A, Rai M, Chakravarty J. Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: a phase 2 study. Am J Trop Med Hyg. 2015;92:513\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"2424_CR31","first-page":"103","volume":"33","author":"V Ramesh","year":"2008","unstructured":"Ramesh V, Ansari N, Jain RK, Salotra P. Oral miltefosine in the treatment of post-kala-azar dermal leishmaniasis. Clin Exp Dermatol. 2008;33:103\u20135.","journal-title":"Clin Exp Dermatol"},{"key":"2424_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/cid\/cis474","volume":"55","author":"S Sundar","year":"2012","unstructured":"Sundar S, Singh A, Rai M, Prajapati VK, Singh AK, Ostyn B, et al. Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis. 2012;55:543\u201350.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-2424-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-015-2424-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-015-2424-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T01:12:15Z","timestamp":1718154735000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-015-2424-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,26]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2424"],"URL":"https:\/\/doi.org\/10.1186\/s12889-015-2424-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,26]]},"article-number":"1092"}}